November 2026

Alfabs Australia will pay $2.0 million upfront for J&J Vac’s underground mining pump assets, with a further $2.0 million available if it manufactures and hires or sells 25 additional units. The deal adds eight pumps, OEM rights and four transferred customer orders while the company continues its debt restructuring process.

Starpharma is targeting a December start for first-in-human testing of its lead DEP HER2-Lu radiopharmaceutical, subject to ethics approval, as it shifts decisively toward targeted oncology. The company also outlined stronger funding, majority ownership of Petalion’s FAP program and a proposed Chair transition at its 2026 AGM.

Lindsay Australia has crossed $1 billion in annual revenue for the first time, with underlying EBIT up 37.7% to $60.4 million. The logistics group is now turning from major network investment to extracting returns, even as softer freight volumes and lower horticultural yields cloud FY27.

The Colonial Motor Company delivered a stronger FY2026 result, but warned that first-quarter earnings have come under pressure as Chinese vehicle brands and new energy vehicles reshape New Zealand’s automotive market. The company is responding with BYD and JAC investments while preserving its conservative balance sheet.

BTC Health has expanded its exclusive ExoVasc PEARS distribution rights from Australia into India under a new five-year agreement. The opportunity is potentially significant, but Indian sales remain dependent on CDSCO import approval.

ADX Energy has begun an eight-week Austrian well work program targeting up to 115 BOEPD of incremental oil and gas production, while preparing HOCH-1 for deeper gas testing. The work spans two Vienna Basin completions, a pump replacement and a test of Hall Channel reservoirs with potential for broader lateral extension.

Tourism Holdings is reviewing revised non-binding proposals from both the BGH consortium and Indie Campers, while reporting a 34% rise in FY26 underlying profit. The stronger result comes with unresolved questions around the US business, weak RV sales and the timing of its $100 million profit ambition.

Clinuvel has outlined a multi-year expansion from peptide therapeutics into polymers, long-acting injectables, devices and digital health, backed by A$220 million of planned FY2027-FY2030 spending. The strategy comes with a near-term setback: first patient treatment in the CUV107 vitiligo study has been delayed to February 2027.

ACDC Metals has begun field work at its Mount Jackson project in Nevada, with geophysics and civil works now underway ahead of a planned maiden drill campaign. The company expects to complete a 12 line-kilometre CSAMT survey and begin up to 2,500 metres of reverse circulation drilling in the fourth quarter of 2026.

Asara Resources has intersected 38 metres at 2.1g/t gold in oxide at Sogosogoba, an exploration target 8km from its Massan deposit in Guinea. The early result strengthens the case for follow-up drilling, but the discovery remains based on only five first-pass holes.

US Medicare has set a national outpatient payment of US$31,265 for Epiminder’s Minder System implant procedure from 1 January 2027, up 13% on the 2026 rate. The decision gives hospitals a defined reimbursement benchmark ahead of Epiminder’s planned US commercial launch.

Riversgold has locked in $1.55 million from sophisticated and professional investors to fund its E25/594 acquisition from Black Cat Syndicate. The deal would expand the Kalgoorlie-Northern Zone Project nearly 15-fold, but more than 258 million new shares will be issued across two tranches.

Peet has executed the implementation deed for a joint venture that would give BNI 49.9% of its Flagstone City project at an agreed inventory value of $615 million. The deal removes a key hurdle in Ingenia’s proposed acquisition of Peet, although other conditions remain outstanding.

Jumbo Interactive delivered record FY26 earnings despite a weak Australian jackpot cycle and reaffirmed its FY27 targets. The company is also pursuing a conditional A$6.45 million acquisition in Ontario while preparing for a CFO transition.

Avenira has raised $48.87 million through its rights issue and shortfall placement, with major shareholder Hebang among those taking up entitlements. Combined with $85 million of debt facilities, the company expects the funding to cover the direct shipping ore phase at Wonarah ahead of planned first shipment in the first half of 2027.

Nine Entertainment has maintained its forecast for revenue and EBITDA growth in FY27, while lifting its expected annualised cost savings target to at least A$180 million. Outdoor, Stan and digital publishing are carrying more of the group’s earnings, although Total Television revenue remains under pressure and shareholder support for executive remuneration was less emphatic.

Regency Centers lifted its 2026 outlook and increased its quarterly common dividend by 6% after stronger third-quarter operating results. The upbeat performance came alongside a sharp decline in GAAP net income, driven partly by a US$65.1 million real estate impairment charge.

Count has completed a fully underwritten $25.0 million institutional placement to help fund its planned acquisition of a 75% interest in Skybridge Financial Group. The acquisition still requires ACCC clearance or a notification waiver before completion, targeted for Q3 FY2027.

NextEra Energy has set out the preliminary financial shape of its proposed Dominion Energy acquisition, including US$62.1 billion of consideration and US$35.7 billion in goodwill. The transaction remains subject to regulatory approvals and other closing conditions, while the accounting estimates could change materially before completion.

Mayne Pharma will sell its international operations, including the Salisbury manufacturing site, to Evaris Pharma for $55.5 million in cash. The deal leaves the company focused entirely on its US Women’s Health, Dermatology and DistributeRx businesses, subject to ACCC approval.

Con Edison delivered stronger third-quarter earnings and tightened its full-year adjusted EPS range, while positioning electrification and infrastructure spending as the next leg of growth. The picture is less clean beneath the headline, with year-to-date GAAP profit boosted by a Mountain Valley Pipeline sale and further equity issuance still ahead.

Qantas says resilient travel demand is keeping FY27 trading in line with its August outlook, despite a sharply higher fuel burden. The airline has maintained its revenue growth guidance while trimming planned capital expenditure to the lower end of its range.

Hammer Metals has set 13 November for the Federal Court to consider approval of Austral Resources Australia’s proposed acquisition of the company. The hearing comes after shareholders are due to vote on the scheme and a linked demerger on 9 November.

American Water and Essential Utilities have reached a settlement with all parties in a New Jersey regulatory proceeding over their proposed merger. The agreement still requires approval from the New Jersey Board of Public Utilities, and its substantive terms have not been disclosed in the filing.